True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to gain weight. The FDA and CDC jointly recommended to pause use of the ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

As weight loss injections dominate the headlines, many wonder whether these so-called miracle drugs are truly safe, what ...

COMMENT: Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes ...

On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...